Sante Capital Fund, LP Allakos Inc. Transaction History

Sante Capital Fund, LP

  • $48.9 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 01, 2022
SELL
$8.55 - $111.89 $164,655 - $2.15 Million
-19,258 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$76.53 - $110.43 $1.83 Million - $2.64 Million
-23,932 Reduced 55.41%
19,258 $2.04 Million
Q2 2021

Aug 16, 2021
BUY
$85.37 - $114.1 $3.69 Million - $4.93 Million
43,190 New
43,190 $3.69 Million

Others Institutions Holding ALLK

# of Institutions
96
Shares Held
70.7M
Call Options Held
43.8K
Put Options Held
1.4K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $106M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Sante Capital Fund, LP Portfolio

Follow Sante Capital Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sante Capital Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sante Capital Fund, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email